Working to Eradicate Gynecologic Cancers

Elise C. Kohn, MD

Senior Investigator and Head, Gynecologic Therapeutics
National Cancer Institute
9609 Medical Center Drive
Bethesda, MD
USA 20892-9737


Biographical Sketch:
Dr. Kohn trained in medicine and Internal Medicine at the University of Michigan Medical School before coming to the National Cancer Institute for her medical oncology fellowship. Dr. Kohn has been at the NCI, investigating therapeutic targets in the signaling of invasion and angiogenesis and drug development focused for ovarian cancer patients while maintaining a clinical program in early phase clinical trials for ovarian cancer. In parallel, her clinical work has evolved to include the newest targeted therapies and proteomic technologies applied to clinical trials."

Papers:
100 Distinct immune characteristics in women with deleterious germline BRCA1/2 mutations (gBRCAm)-associated high-grade serous ovarian cancer (HGSOC) Introductory Remarks for Avoiding Clinical Catastrophes Distillation - Biomarkers